Enterome
Phase 2We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
Founded
2012
Focus
DiagnosticsMicrobiome
About
We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
Funding History
4Total raised: $135.2M
Series D$56.7MSymBiosisJun 15, 2021
Series C$46.5MSeventure PartnersJun 15, 2018
Series B$17MSeventure PartnersJun 15, 2015
Series A$15MSeventure PartnersJun 15, 2012
Company Info
TypePrivate
Founded2012
LocationParis, France
StagePhase 2
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile